As COVID Continues to Wane, Will Additional Booster Shots Be Needed?

1.30K
121
Favorite

As COVID Continues to Wane, Will Additional Booster Shots Be Needed?

seekingalpha2022-03-06

As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

1.30K

Report

Comment（121）

DragonKC
·2022-03-07
Vaccines stocks tumbling as more countries opening up. Omicron waning as mutation variants getting weaker becoming like normal cold n flu.
Reply
1
Report
RK0948
·2022-03-07
Point of producer is Yes
Reply
Like
Report
RK0948
·2022-03-07
NonSense
Reply
Like
Report
Cvt
·2022-03-07
Might be new and better vaccine out soon
Reply
1
Report
robot1234
·2022-03-07
Better to err on safe side and not stay too long with the vaccine producers such as Pfizer and Moderna
Reply
3
Report
Ah Deck
·2022-03-07
Share price drop a lot!🤦🏼‍♀️...hold or cut loss? comment & like
Reply
1
Report
newwen
·2022-03-07
Up
Reply
5
Report
KFChen
·2022-03-07
Hopefully not!
Reply
1
Report
HF133
·2022-03-07
Ok
Reply
2
Report
SiminC
·2022-03-07
yes
Reply
4
Report
i am ok
·2022-03-07
ok
Reply
3
Report
KarenChia
·2022-03-07
Like
Reply
3
Report
jerwy
·2022-03-07
wow
Reply
3
Report
Pierre0520
·2022-03-07
L
Reply
3
Report
linereps
·2022-03-07
Hope not
Reply
4
Report
bluewave
·2022-03-07
Like please
Reply
6
Report
HOME RUN
·2022-03-07
Pls like
Reply
6
Report
Leckyyy
·2022-03-07
Like
Reply
4
Report
Arnoldy
·2022-03-07
Like
Reply
5
Report
angskk
·2022-03-07
Pls like
Reply
5
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2217049529?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-03-06 10:26","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2217049529","market":"us","top_or_hot":-1,"title":"As COVID Continues to Wane, Will Additional Booster Shots Be Needed?","media":"seekingalpha","content":"<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As COVID Continues to Wane, Will Additional Booster Shots Be Needed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs COVID Continues to Wane, Will Additional Booster Shots Be Needed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-06 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4551","symbol_name":"寇图资本持仓","start_time":0,"source_url":"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed","article_id":"2217049529","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2217049529","pubTimestamp":1646533561,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to mo","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4551":"寇图资本持仓","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BNTX":"BioNTech SE","NVAX":"诺瓦瓦克斯医药","BK4534":"瑞士信贷持仓","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4581":"高盛持仓","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4007":"制药","MRNA":"Moderna, Inc.","BK4532":"文艺复兴科技持仓"},"translate_title":"随着COVID的继续减弱，还需要额外的加强注射吗？","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BNTX":1,"MRNA":1,"NVAX":1,"PFE":1},"content_text":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven't come out to endorse additional boosters.In an interview with The New York Times last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn't enough data yet to make a determination on a fourth shot.Another recent Times article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.\"We're starting to see now diminishing returns on the number of additional doses,\" John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9031486537,"gmtCreate":1646644538747,"gmtModify":1676534146223,"author":{"id":"3577178099298017","authorId":"3577178099298017","name":"DragonKC","avatar":"https://static.tigerbbs.com/f90c63c67a4e5f91e9dc0159f5b853ab","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Vaccines stocks tumbling as more countries opening up.&nbsp; Omicron waning as mutation variants getting weaker becoming like normal cold n flu.&nbsp;","listText":"Vaccines stocks tumbling as more countries opening up.&nbsp; Omicron waning as mutation variants getting weaker becoming like normal cold n flu.&nbsp;","text":"Vaccines stocks tumbling as more countries opening up. Omicron waning as mutation variants getting weaker becoming like normal cold n flu.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031486537","repostId":2217049529,"repostType":2,"repost":{"id":"2217049529","pubTimestamp":1646533561,"share":"https://www.laohu8.com/m/news/2217049529?lang=&edition=full","pubTime":"2022-03-06 10:26","market":"us","language":"en","title":"As COVID Continues to Wane, Will Additional Booster Shots Be Needed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2217049529","media":"seekingalpha","summary":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to mo","content":"<html><head></head><body><p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.</p><p>There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven&#39;t come out to endorse additional boosters.</p><p>In an interview with <i>The New York Times</i> last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.</p><p>In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn&#39;t enough data yet to make a determination on a fourth shot.</p><p>Another recent <i>Times</i> article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.</p><p>&#34;We&#39;re starting to see now diminishing returns on the number of additional doses,&#34; John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.</p><p>A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.</p><p>The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).</p><p>However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.</p><p>There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As COVID Continues to Wane, Will Additional Booster Shots Be Needed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs COVID Continues to Wane, Will Additional Booster Shots Be Needed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-06 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4007":"制药","NVAX":"诺瓦瓦克斯医药","BK4532":"文艺复兴科技持仓","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2217049529","content_text":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven't come out to endorse additional boosters.In an interview with The New York Times last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn't enough data yet to make a determination on a fourth shot.Another recent Times article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.\"We're starting to see now diminishing returns on the number of additional doses,\" John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9031563343,"gmtCreate":1646616793038,"gmtModify":1676534143760,"author":{"id":"3572004565657160","authorId":"3572004565657160","name":"RK0948","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":5,"crmLevelSwitch":1},"htmlText":"Point of producer is Yes","listText":"Point of producer is Yes","text":"Point of producer is Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031563343","repostId":2217049529,"repostType":2,"repost":{"id":"2217049529","pubTimestamp":1646533561,"share":"https://www.laohu8.com/m/news/2217049529?lang=&edition=full","pubTime":"2022-03-06 10:26","market":"us","language":"en","title":"As COVID Continues to Wane, Will Additional Booster Shots Be Needed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2217049529","media":"seekingalpha","summary":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to mo","content":"<html><head></head><body><p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.</p><p>There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven&#39;t come out to endorse additional boosters.</p><p>In an interview with <i>The New York Times</i> last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.</p><p>In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn&#39;t enough data yet to make a determination on a fourth shot.</p><p>Another recent <i>Times</i> article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.</p><p>&#34;We&#39;re starting to see now diminishing returns on the number of additional doses,&#34; John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.</p><p>A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.</p><p>The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).</p><p>However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.</p><p>There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As COVID Continues to Wane, Will Additional Booster Shots Be Needed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs COVID Continues to Wane, Will Additional Booster Shots Be Needed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-06 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4007":"制药","NVAX":"诺瓦瓦克斯医药","BK4532":"文艺复兴科技持仓","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2217049529","content_text":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven't come out to endorse additional boosters.In an interview with The New York Times last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn't enough data yet to make a determination on a fourth shot.Another recent Times article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.\"We're starting to see now diminishing returns on the number of additional doses,\" John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9031560289,"gmtCreate":1646616508666,"gmtModify":1676534143721,"author":{"id":"3572004565657160","authorId":"3572004565657160","name":"RK0948","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":5,"crmLevelSwitch":1},"htmlText":"NonSense&nbsp;","listText":"NonSense&nbsp;","text":"NonSense","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031560289","repostId":2217049529,"repostType":2,"repost":{"id":"2217049529","pubTimestamp":1646533561,"share":"https://www.laohu8.com/m/news/2217049529?lang=&edition=full","pubTime":"2022-03-06 10:26","market":"us","language":"en","title":"As COVID Continues to Wane, Will Additional Booster Shots Be Needed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2217049529","media":"seekingalpha","summary":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to mo","content":"<html><head></head><body><p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.</p><p>There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven&#39;t come out to endorse additional boosters.</p><p>In an interview with <i>The New York Times</i> last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.</p><p>In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn&#39;t enough data yet to make a determination on a fourth shot.</p><p>Another recent <i>Times</i> article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.</p><p>&#34;We&#39;re starting to see now diminishing returns on the number of additional doses,&#34; John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.</p><p>A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.</p><p>The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).</p><p>However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.</p><p>There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As COVID Continues to Wane, Will Additional Booster Shots Be Needed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs COVID Continues to Wane, Will Additional Booster Shots Be Needed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-06 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4007":"制药","NVAX":"诺瓦瓦克斯医药","BK4532":"文艺复兴科技持仓","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2217049529","content_text":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven't come out to endorse additional boosters.In an interview with The New York Times last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn't enough data yet to make a determination on a fourth shot.Another recent Times article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.\"We're starting to see now diminishing returns on the number of additional doses,\" John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9031599097,"gmtCreate":1646611749547,"gmtModify":1676534142700,"author":{"id":"3579235597126488","authorId":"3579235597126488","name":"Cvt","avatar":"https://static.tigerbbs.com/c8fda02901ec7a98b51fe8e84d016ab2","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Might be new and better&nbsp;vaccine out soon","listText":"Might be new and better&nbsp;vaccine out soon","text":"Might be new and better vaccine out soon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031599097","repostId":2217049529,"repostType":4,"repost":{"id":"2217049529","pubTimestamp":1646533561,"share":"https://www.laohu8.com/m/news/2217049529?lang=&edition=full","pubTime":"2022-03-06 10:26","market":"us","language":"en","title":"As COVID Continues to Wane, Will Additional Booster Shots Be Needed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2217049529","media":"seekingalpha","summary":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to mo","content":"<html><head></head><body><p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.</p><p>There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven&#39;t come out to endorse additional boosters.</p><p>In an interview with <i>The New York Times</i> last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.</p><p>In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn&#39;t enough data yet to make a determination on a fourth shot.</p><p>Another recent <i>Times</i> article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.</p><p>&#34;We&#39;re starting to see now diminishing returns on the number of additional doses,&#34; John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.</p><p>A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.</p><p>The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).</p><p>However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.</p><p>There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As COVID Continues to Wane, Will Additional Booster Shots Be Needed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs COVID Continues to Wane, Will Additional Booster Shots Be Needed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-06 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4007":"制药","NVAX":"诺瓦瓦克斯医药","BK4532":"文艺复兴科技持仓","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2217049529","content_text":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven't come out to endorse additional boosters.In an interview with The New York Times last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn't enough data yet to make a determination on a fourth shot.Another recent Times article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.\"We're starting to see now diminishing returns on the number of additional doses,\" John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9031507357,"gmtCreate":1646611527505,"gmtModify":1676534142662,"author":{"id":"3561596430587504","authorId":"3561596430587504","name":"robot1234","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":6,"crmLevelSwitch":1},"htmlText":"Better to err on safe side and not stay too long with the vaccine producers&nbsp;such as Pfizer&nbsp;and Moderna","listText":"Better to err on safe side and not stay too long with the vaccine producers&nbsp;such as Pfizer&nbsp;and Moderna","text":"Better to err on safe side and not stay too long with the vaccine producers such as Pfizer and Moderna","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031507357","repostId":2217049529,"repostType":4,"repost":{"id":"2217049529","pubTimestamp":1646533561,"share":"https://www.laohu8.com/m/news/2217049529?lang=&edition=full","pubTime":"2022-03-06 10:26","market":"us","language":"en","title":"As COVID Continues to Wane, Will Additional Booster Shots Be Needed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2217049529","media":"seekingalpha","summary":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to mo","content":"<html><head></head><body><p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.</p><p>There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven&#39;t come out to endorse additional boosters.</p><p>In an interview with <i>The New York Times</i> last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.</p><p>In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn&#39;t enough data yet to make a determination on a fourth shot.</p><p>Another recent <i>Times</i> article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.</p><p>&#34;We&#39;re starting to see now diminishing returns on the number of additional doses,&#34; John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.</p><p>A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.</p><p>The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).</p><p>However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.</p><p>There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As COVID Continues to Wane, Will Additional Booster Shots Be Needed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs COVID Continues to Wane, Will Additional Booster Shots Be Needed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-06 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4007":"制药","NVAX":"诺瓦瓦克斯医药","BK4532":"文艺复兴科技持仓","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2217049529","content_text":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven't come out to endorse additional boosters.In an interview with The New York Times last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn't enough data yet to make a determination on a fourth shot.Another recent Times article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.\"We're starting to see now diminishing returns on the number of additional doses,\" John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9031277828,"gmtCreate":1646610446954,"gmtModify":1676534142430,"author":{"id":"4098445225447010","authorId":"4098445225447010","name":"Ah Deck","avatar":"https://static.tigerbbs.com/0e52eb1e14e0f630d24f1687ea546cd8","vip":1,"crmLevel":3,"crmLevelSwitch":1},"htmlText":"Share price drop a lot!🤦🏼‍♀️...hold or cut loss?&nbsp;comment &amp; like&nbsp;","listText":"Share price drop a lot!🤦🏼‍♀️...hold or cut loss?&nbsp;comment &amp; like&nbsp;","text":"Share price drop a lot!🤦🏼‍♀️...hold or cut loss? comment & like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031277828","repostId":2217049529,"repostType":4,"repost":{"id":"2217049529","pubTimestamp":1646533561,"share":"https://www.laohu8.com/m/news/2217049529?lang=&edition=full","pubTime":"2022-03-06 10:26","market":"us","language":"en","title":"As COVID Continues to Wane, Will Additional Booster Shots Be Needed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2217049529","media":"seekingalpha","summary":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to mo","content":"<html><head></head><body><p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.</p><p>There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven&#39;t come out to endorse additional boosters.</p><p>In an interview with <i>The New York Times</i> last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.</p><p>In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn&#39;t enough data yet to make a determination on a fourth shot.</p><p>Another recent <i>Times</i> article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.</p><p>&#34;We&#39;re starting to see now diminishing returns on the number of additional doses,&#34; John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.</p><p>A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.</p><p>The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).</p><p>However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.</p><p>There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As COVID Continues to Wane, Will Additional Booster Shots Be Needed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs COVID Continues to Wane, Will Additional Booster Shots Be Needed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-06 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4007":"制药","NVAX":"诺瓦瓦克斯医药","BK4532":"文艺复兴科技持仓","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2217049529","content_text":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven't come out to endorse additional boosters.In an interview with The New York Times last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn't enough data yet to make a determination on a fourth shot.Another recent Times article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.\"We're starting to see now diminishing returns on the number of additional doses,\" John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9031270521,"gmtCreate":1646609682442,"gmtModify":1676534142232,"author":{"id":"3577937302028167","authorId":"3577937302028167","name":"newwen","avatar":"https://community-static.tradeup.com/news/d76e150284d102a1d312d08f6f90af41","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031270521","repostId":2217049529,"repostType":4,"repost":{"id":"2217049529","pubTimestamp":1646533561,"share":"https://www.laohu8.com/m/news/2217049529?lang=&edition=full","pubTime":"2022-03-06 10:26","market":"us","language":"en","title":"As COVID Continues to Wane, Will Additional Booster Shots Be Needed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2217049529","media":"seekingalpha","summary":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to mo","content":"<html><head></head><body><p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.</p><p>There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven&#39;t come out to endorse additional boosters.</p><p>In an interview with <i>The New York Times</i> last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.</p><p>In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn&#39;t enough data yet to make a determination on a fourth shot.</p><p>Another recent <i>Times</i> article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.</p><p>&#34;We&#39;re starting to see now diminishing returns on the number of additional doses,&#34; John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.</p><p>A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.</p><p>The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).</p><p>However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.</p><p>There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As COVID Continues to Wane, Will Additional Booster Shots Be Needed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs COVID Continues to Wane, Will Additional Booster Shots Be Needed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-06 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4007":"制药","NVAX":"诺瓦瓦克斯医药","BK4532":"文艺复兴科技持仓","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2217049529","content_text":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven't come out to endorse additional boosters.In an interview with The New York Times last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn't enough data yet to make a determination on a fourth shot.Another recent Times article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.\"We're starting to see now diminishing returns on the number of additional doses,\" John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9031246018,"gmtCreate":1646608983480,"gmtModify":1676534142080,"author":{"id":"3576990193651421","authorId":"3576990193651421","name":"KFChen","avatar":"https://static.tigerbbs.com/6830fa3fe8a82d29953fbb2e6153801e","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Hopefully not!","listText":"Hopefully not!","text":"Hopefully not!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031246018","repostId":2217049529,"repostType":4,"repost":{"id":"2217049529","pubTimestamp":1646533561,"share":"https://www.laohu8.com/m/news/2217049529?lang=&edition=full","pubTime":"2022-03-06 10:26","market":"us","language":"en","title":"As COVID Continues to Wane, Will Additional Booster Shots Be Needed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2217049529","media":"seekingalpha","summary":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to mo","content":"<html><head></head><body><p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.</p><p>There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven&#39;t come out to endorse additional boosters.</p><p>In an interview with <i>The New York Times</i> last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.</p><p>In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn&#39;t enough data yet to make a determination on a fourth shot.</p><p>Another recent <i>Times</i> article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.</p><p>&#34;We&#39;re starting to see now diminishing returns on the number of additional doses,&#34; John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.</p><p>A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.</p><p>The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).</p><p>However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.</p><p>There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As COVID Continues to Wane, Will Additional Booster Shots Be Needed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs COVID Continues to Wane, Will Additional Booster Shots Be Needed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-06 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4007":"制药","NVAX":"诺瓦瓦克斯医药","BK4532":"文艺复兴科技持仓","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2217049529","content_text":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven't come out to endorse additional boosters.In an interview with The New York Times last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn't enough data yet to make a determination on a fourth shot.Another recent Times article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.\"We're starting to see now diminishing returns on the number of additional doses,\" John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9031248327,"gmtCreate":1646608911020,"gmtModify":1676534142064,"author":{"id":"3583621807888930","authorId":"3583621807888930","name":"HF133","avatar":"https://static.tigerbbs.com/ce211305e06a021e08ecfcbc0e23bbb5","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031248327","repostId":2217049529,"repostType":4,"repost":{"id":"2217049529","pubTimestamp":1646533561,"share":"https://www.laohu8.com/m/news/2217049529?lang=&edition=full","pubTime":"2022-03-06 10:26","market":"us","language":"en","title":"As COVID Continues to Wane, Will Additional Booster Shots Be Needed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2217049529","media":"seekingalpha","summary":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to mo","content":"<html><head></head><body><p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.</p><p>There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven&#39;t come out to endorse additional boosters.</p><p>In an interview with <i>The New York Times</i> last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.</p><p>In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn&#39;t enough data yet to make a determination on a fourth shot.</p><p>Another recent <i>Times</i> article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.</p><p>&#34;We&#39;re starting to see now diminishing returns on the number of additional doses,&#34; John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.</p><p>A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.</p><p>The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).</p><p>However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.</p><p>There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As COVID Continues to Wane, Will Additional Booster Shots Be Needed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs COVID Continues to Wane, Will Additional Booster Shots Be Needed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-06 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4007":"制药","NVAX":"诺瓦瓦克斯医药","BK4532":"文艺复兴科技持仓","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2217049529","content_text":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven't come out to endorse additional boosters.In an interview with The New York Times last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn't enough data yet to make a determination on a fourth shot.Another recent Times article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.\"We're starting to see now diminishing returns on the number of additional doses,\" John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9031241472,"gmtCreate":1646608871087,"gmtModify":1676534142047,"author":{"id":"4088941312412870","authorId":"4088941312412870","name":"SiminC","avatar":"https://static.tigerbbs.com/fabe2f6446b7deb3e55a6cdd5a233455","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"yes","listText":"yes","text":"yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031241472","repostId":2217049529,"repostType":4,"repost":{"id":"2217049529","pubTimestamp":1646533561,"share":"https://www.laohu8.com/m/news/2217049529?lang=&edition=full","pubTime":"2022-03-06 10:26","market":"us","language":"en","title":"As COVID Continues to Wane, Will Additional Booster Shots Be Needed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2217049529","media":"seekingalpha","summary":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to mo","content":"<html><head></head><body><p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.</p><p>There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven&#39;t come out to endorse additional boosters.</p><p>In an interview with <i>The New York Times</i> last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.</p><p>In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn&#39;t enough data yet to make a determination on a fourth shot.</p><p>Another recent <i>Times</i> article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.</p><p>&#34;We&#39;re starting to see now diminishing returns on the number of additional doses,&#34; John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.</p><p>A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.</p><p>The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).</p><p>However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.</p><p>There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As COVID Continues to Wane, Will Additional Booster Shots Be Needed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs COVID Continues to Wane, Will Additional Booster Shots Be Needed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-06 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4007":"制药","NVAX":"诺瓦瓦克斯医药","BK4532":"文艺复兴科技持仓","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2217049529","content_text":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven't come out to endorse additional boosters.In an interview with The New York Times last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn't enough data yet to make a determination on a fourth shot.Another recent Times article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.\"We're starting to see now diminishing returns on the number of additional doses,\" John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9031241820,"gmtCreate":1646608812396,"gmtModify":1676534141980,"author":{"id":"3583010094291363","authorId":"3583010094291363","name":"i am ok","avatar":"https://static.tigerbbs.com/a3e36ab40e4050fb2c6704581088947a","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031241820","repostId":2217049529,"repostType":4,"repost":{"id":"2217049529","pubTimestamp":1646533561,"share":"https://www.laohu8.com/m/news/2217049529?lang=&edition=full","pubTime":"2022-03-06 10:26","market":"us","language":"en","title":"As COVID Continues to Wane, Will Additional Booster Shots Be Needed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2217049529","media":"seekingalpha","summary":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to mo","content":"<html><head></head><body><p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.</p><p>There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven&#39;t come out to endorse additional boosters.</p><p>In an interview with <i>The New York Times</i> last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.</p><p>In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn&#39;t enough data yet to make a determination on a fourth shot.</p><p>Another recent <i>Times</i> article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.</p><p>&#34;We&#39;re starting to see now diminishing returns on the number of additional doses,&#34; John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.</p><p>A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.</p><p>The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).</p><p>However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.</p><p>There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As COVID Continues to Wane, Will Additional Booster Shots Be Needed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs COVID Continues to Wane, Will Additional Booster Shots Be Needed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-06 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4007":"制药","NVAX":"诺瓦瓦克斯医药","BK4532":"文艺复兴科技持仓","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2217049529","content_text":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven't come out to endorse additional boosters.In an interview with The New York Times last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn't enough data yet to make a determination on a fourth shot.Another recent Times article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.\"We're starting to see now diminishing returns on the number of additional doses,\" John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9031241961,"gmtCreate":1646608804022,"gmtModify":1676534141973,"author":{"id":"3586087274164016","authorId":"3586087274164016","name":"KarenChia","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031241961","repostId":2217049529,"repostType":4,"repost":{"id":"2217049529","pubTimestamp":1646533561,"share":"https://www.laohu8.com/m/news/2217049529?lang=&edition=full","pubTime":"2022-03-06 10:26","market":"us","language":"en","title":"As COVID Continues to Wane, Will Additional Booster Shots Be Needed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2217049529","media":"seekingalpha","summary":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to mo","content":"<html><head></head><body><p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.</p><p>There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven&#39;t come out to endorse additional boosters.</p><p>In an interview with <i>The New York Times</i> last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.</p><p>In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn&#39;t enough data yet to make a determination on a fourth shot.</p><p>Another recent <i>Times</i> article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.</p><p>&#34;We&#39;re starting to see now diminishing returns on the number of additional doses,&#34; John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.</p><p>A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.</p><p>The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).</p><p>However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.</p><p>There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As COVID Continues to Wane, Will Additional Booster Shots Be Needed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs COVID Continues to Wane, Will Additional Booster Shots Be Needed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-06 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4007":"制药","NVAX":"诺瓦瓦克斯医药","BK4532":"文艺复兴科技持仓","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2217049529","content_text":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven't come out to endorse additional boosters.In an interview with The New York Times last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn't enough data yet to make a determination on a fourth shot.Another recent Times article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.\"We're starting to see now diminishing returns on the number of additional doses,\" John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9031249606,"gmtCreate":1646608489220,"gmtModify":1676534141933,"author":{"id":"3579412043719168","authorId":"3579412043719168","name":"jerwy","avatar":"https://static.tigerbbs.com/fdc16e3a47a2704d68f0ff55284feb48","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":4,"crmLevelSwitch":1},"htmlText":"wow","listText":"wow","text":"wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031249606","repostId":2217049529,"repostType":4,"repost":{"id":"2217049529","pubTimestamp":1646533561,"share":"https://www.laohu8.com/m/news/2217049529?lang=&edition=full","pubTime":"2022-03-06 10:26","market":"us","language":"en","title":"As COVID Continues to Wane, Will Additional Booster Shots Be Needed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2217049529","media":"seekingalpha","summary":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to mo","content":"<html><head></head><body><p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.</p><p>There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven&#39;t come out to endorse additional boosters.</p><p>In an interview with <i>The New York Times</i> last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.</p><p>In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn&#39;t enough data yet to make a determination on a fourth shot.</p><p>Another recent <i>Times</i> article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.</p><p>&#34;We&#39;re starting to see now diminishing returns on the number of additional doses,&#34; John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.</p><p>A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.</p><p>The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).</p><p>However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.</p><p>There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As COVID Continues to Wane, Will Additional Booster Shots Be Needed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs COVID Continues to Wane, Will Additional Booster Shots Be Needed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-06 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4007":"制药","NVAX":"诺瓦瓦克斯医药","BK4532":"文艺复兴科技持仓","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2217049529","content_text":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven't come out to endorse additional boosters.In an interview with The New York Times last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn't enough data yet to make a determination on a fourth shot.Another recent Times article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.\"We're starting to see now diminishing returns on the number of additional doses,\" John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9031249305,"gmtCreate":1646608472036,"gmtModify":1676534141941,"author":{"id":"4087619312283300","authorId":"4087619312283300","name":"Pierre0520","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031249305","repostId":2217049529,"repostType":4,"repost":{"id":"2217049529","pubTimestamp":1646533561,"share":"https://www.laohu8.com/m/news/2217049529?lang=&edition=full","pubTime":"2022-03-06 10:26","market":"us","language":"en","title":"As COVID Continues to Wane, Will Additional Booster Shots Be Needed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2217049529","media":"seekingalpha","summary":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to mo","content":"<html><head></head><body><p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.</p><p>There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven&#39;t come out to endorse additional boosters.</p><p>In an interview with <i>The New York Times</i> last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.</p><p>In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn&#39;t enough data yet to make a determination on a fourth shot.</p><p>Another recent <i>Times</i> article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.</p><p>&#34;We&#39;re starting to see now diminishing returns on the number of additional doses,&#34; John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.</p><p>A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.</p><p>The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).</p><p>However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.</p><p>There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As COVID Continues to Wane, Will Additional Booster Shots Be Needed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs COVID Continues to Wane, Will Additional Booster Shots Be Needed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-06 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4007":"制药","NVAX":"诺瓦瓦克斯医药","BK4532":"文艺复兴科技持仓","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2217049529","content_text":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven't come out to endorse additional boosters.In an interview with The New York Times last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn't enough data yet to make a determination on a fourth shot.Another recent Times article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.\"We're starting to see now diminishing returns on the number of additional doses,\" John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9031240468,"gmtCreate":1646608404702,"gmtModify":1676534141918,"author":{"id":"3571046202315678","authorId":"3571046202315678","name":"linereps","avatar":"https://static.tigerbbs.com/3d348014f82002028e364ade841b3433","vip":1,"crmLevel":7,"crmLevelSwitch":1},"htmlText":"Hope not&nbsp;","listText":"Hope not&nbsp;","text":"Hope not","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031240468","repostId":2217049529,"repostType":4,"repost":{"id":"2217049529","pubTimestamp":1646533561,"share":"https://www.laohu8.com/m/news/2217049529?lang=&edition=full","pubTime":"2022-03-06 10:26","market":"us","language":"en","title":"As COVID Continues to Wane, Will Additional Booster Shots Be Needed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2217049529","media":"seekingalpha","summary":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to mo","content":"<html><head></head><body><p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.</p><p>There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven&#39;t come out to endorse additional boosters.</p><p>In an interview with <i>The New York Times</i> last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.</p><p>In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn&#39;t enough data yet to make a determination on a fourth shot.</p><p>Another recent <i>Times</i> article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.</p><p>&#34;We&#39;re starting to see now diminishing returns on the number of additional doses,&#34; John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.</p><p>A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.</p><p>The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).</p><p>However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.</p><p>There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As COVID Continues to Wane, Will Additional Booster Shots Be Needed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs COVID Continues to Wane, Will Additional Booster Shots Be Needed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-06 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4007":"制药","NVAX":"诺瓦瓦克斯医药","BK4532":"文艺复兴科技持仓","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2217049529","content_text":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven't come out to endorse additional boosters.In an interview with The New York Times last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn't enough data yet to make a determination on a fourth shot.Another recent Times article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.\"We're starting to see now diminishing returns on the number of additional doses,\" John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9031240612,"gmtCreate":1646608376663,"gmtModify":1676534141910,"author":{"id":"3578259981610721","authorId":"3578259981610721","name":"bluewave","avatar":"https://static.tigerbbs.com/8e71f1454119ff144295c97018b0ca47","vip":1,"crmLevel":5,"crmLevelSwitch":1},"htmlText":"Like please&nbsp;","listText":"Like please&nbsp;","text":"Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031240612","repostId":2217049529,"repostType":4,"repost":{"id":"2217049529","pubTimestamp":1646533561,"share":"https://www.laohu8.com/m/news/2217049529?lang=&edition=full","pubTime":"2022-03-06 10:26","market":"us","language":"en","title":"As COVID Continues to Wane, Will Additional Booster Shots Be Needed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2217049529","media":"seekingalpha","summary":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to mo","content":"<html><head></head><body><p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.</p><p>There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven&#39;t come out to endorse additional boosters.</p><p>In an interview with <i>The New York Times</i> last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.</p><p>In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn&#39;t enough data yet to make a determination on a fourth shot.</p><p>Another recent <i>Times</i> article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.</p><p>&#34;We&#39;re starting to see now diminishing returns on the number of additional doses,&#34; John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.</p><p>A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.</p><p>The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).</p><p>However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.</p><p>There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As COVID Continues to Wane, Will Additional Booster Shots Be Needed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs COVID Continues to Wane, Will Additional Booster Shots Be Needed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-06 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4007":"制药","NVAX":"诺瓦瓦克斯医药","BK4532":"文艺复兴科技持仓","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2217049529","content_text":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven't come out to endorse additional boosters.In an interview with The New York Times last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn't enough data yet to make a determination on a fourth shot.Another recent Times article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.\"We're starting to see now diminishing returns on the number of additional doses,\" John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9031240109,"gmtCreate":1646608318534,"gmtModify":1676534141910,"author":{"id":"3582029020196512","authorId":"3582029020196512","name":"HOME RUN","avatar":"https://static.tigerbbs.com/60421702b647e5c5156fa081ca9a26ff","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":5,"crmLevelSwitch":0},"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031240109","repostId":2217049529,"repostType":4,"repost":{"id":"2217049529","pubTimestamp":1646533561,"share":"https://www.laohu8.com/m/news/2217049529?lang=&edition=full","pubTime":"2022-03-06 10:26","market":"us","language":"en","title":"As COVID Continues to Wane, Will Additional Booster Shots Be Needed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2217049529","media":"seekingalpha","summary":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to mo","content":"<html><head></head><body><p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.</p><p>There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven&#39;t come out to endorse additional boosters.</p><p>In an interview with <i>The New York Times</i> last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.</p><p>In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn&#39;t enough data yet to make a determination on a fourth shot.</p><p>Another recent <i>Times</i> article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.</p><p>&#34;We&#39;re starting to see now diminishing returns on the number of additional doses,&#34; John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.</p><p>A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.</p><p>The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).</p><p>However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.</p><p>There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As COVID Continues to Wane, Will Additional Booster Shots Be Needed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs COVID Continues to Wane, Will Additional Booster Shots Be Needed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-06 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4007":"制药","NVAX":"诺瓦瓦克斯医药","BK4532":"文艺复兴科技持仓","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2217049529","content_text":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven't come out to endorse additional boosters.In an interview with The New York Times last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn't enough data yet to make a determination on a fourth shot.Another recent Times article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.\"We're starting to see now diminishing returns on the number of additional doses,\" John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9031257437,"gmtCreate":1646608197699,"gmtModify":1676534141887,"author":{"id":"3581927528519582","authorId":"3581927528519582","name":"Leckyyy","avatar":"https://static.tigerbbs.com/422496a4ca38a40477f6381eba567268","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":2,"crmLevelSwitch":1},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031257437","repostId":2217049529,"repostType":4,"repost":{"id":"2217049529","pubTimestamp":1646533561,"share":"https://www.laohu8.com/m/news/2217049529?lang=&edition=full","pubTime":"2022-03-06 10:26","market":"us","language":"en","title":"As COVID Continues to Wane, Will Additional Booster Shots Be Needed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2217049529","media":"seekingalpha","summary":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to mo","content":"<html><head></head><body><p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.</p><p>There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven&#39;t come out to endorse additional boosters.</p><p>In an interview with <i>The New York Times</i> last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.</p><p>In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn&#39;t enough data yet to make a determination on a fourth shot.</p><p>Another recent <i>Times</i> article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.</p><p>&#34;We&#39;re starting to see now diminishing returns on the number of additional doses,&#34; John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.</p><p>A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.</p><p>The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).</p><p>However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.</p><p>There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As COVID Continues to Wane, Will Additional Booster Shots Be Needed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs COVID Continues to Wane, Will Additional Booster Shots Be Needed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-06 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4007":"制药","NVAX":"诺瓦瓦克斯医药","BK4532":"文艺复兴科技持仓","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2217049529","content_text":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven't come out to endorse additional boosters.In an interview with The New York Times last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn't enough data yet to make a determination on a fourth shot.Another recent Times article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.\"We're starting to see now diminishing returns on the number of additional doses,\" John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9031257517,"gmtCreate":1646608180256,"gmtModify":1676534141895,"author":{"id":"3577504972179170","authorId":"3577504972179170","name":"Arnoldy","avatar":"https://static.tigerbbs.com/3bfdb559c890249bf261380cb2bd5721","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031257517","repostId":2217049529,"repostType":4,"repost":{"id":"2217049529","pubTimestamp":1646533561,"share":"https://www.laohu8.com/m/news/2217049529?lang=&edition=full","pubTime":"2022-03-06 10:26","market":"us","language":"en","title":"As COVID Continues to Wane, Will Additional Booster Shots Be Needed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2217049529","media":"seekingalpha","summary":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to mo","content":"<html><head></head><body><p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.</p><p>There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven&#39;t come out to endorse additional boosters.</p><p>In an interview with <i>The New York Times</i> last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.</p><p>In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn&#39;t enough data yet to make a determination on a fourth shot.</p><p>Another recent <i>Times</i> article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.</p><p>&#34;We&#39;re starting to see now diminishing returns on the number of additional doses,&#34; John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.</p><p>A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.</p><p>The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).</p><p>However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.</p><p>There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As COVID Continues to Wane, Will Additional Booster Shots Be Needed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs COVID Continues to Wane, Will Additional Booster Shots Be Needed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-06 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4007":"制药","NVAX":"诺瓦瓦克斯医药","BK4532":"文艺复兴科技持仓","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2217049529","content_text":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven't come out to endorse additional boosters.In an interview with The New York Times last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn't enough data yet to make a determination on a fourth shot.Another recent Times article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.\"We're starting to see now diminishing returns on the number of additional doses,\" John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9031257239,"gmtCreate":1646608154374,"gmtModify":1676534141895,"author":{"id":"3575447019432232","authorId":"3575447019432232","name":"angskk","avatar":"https://static.tigerbbs.com/14993a1ab2e959534763e33dc2415981","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031257239","repostId":2217049529,"repostType":4,"repost":{"id":"2217049529","pubTimestamp":1646533561,"share":"https://www.laohu8.com/m/news/2217049529?lang=&edition=full","pubTime":"2022-03-06 10:26","market":"us","language":"en","title":"As COVID Continues to Wane, Will Additional Booster Shots Be Needed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2217049529","media":"seekingalpha","summary":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to mo","content":"<html><head></head><body><p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.</p><p>There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven&#39;t come out to endorse additional boosters.</p><p>In an interview with <i>The New York Times</i> last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.</p><p>In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn&#39;t enough data yet to make a determination on a fourth shot.</p><p>Another recent <i>Times</i> article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.</p><p>&#34;We&#39;re starting to see now diminishing returns on the number of additional doses,&#34; John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.</p><p>A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.</p><p>The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).</p><p>However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.</p><p>There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As COVID Continues to Wane, Will Additional Booster Shots Be Needed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs COVID Continues to Wane, Will Additional Booster Shots Be Needed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-06 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary....</p>\n\n<a href=\"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4007":"制药","NVAX":"诺瓦瓦克斯医药","BK4532":"文艺复兴科技持仓","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3809802-as-covid-continues-to-wane-will-additional-booster-shots-be-needed","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2217049529","content_text":"As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to more of a sense of normalcy. This has many thinking if additional booster shots will be necessary.There is no clear answer at this point. While CDC data in February indicated the effectiveness of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) booster shots subsides after about four months, public health officials haven't come out to endorse additional boosters.In an interview with The New York Times last month, Anthony Fauci, chief medical advisor to the president, said that although he is often asked if a fourth shot is necessary, the protection still afforded by a single booster is good.In the same article, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. FDA, said there isn't enough data yet to make a determination on a fourth shot.Another recent Times article argues that based on several recent studies, another booster is likely not needed for many months, if not longer than that.\"We're starting to see now diminishing returns on the number of additional doses,\" John Wherry, director of the Institute for immunology at the University of Pennsylvania, told the newspaper.A study from Israel of people inoculated with a fourth shot that came out in January found that while it increased the level of antibodies, many people still became ill with the Omicron variant.The need for -- or lack thereof -- additional booster shots could have a significant impact on some of the COVID vaccine makers, especially those whose revenues are reliant on vaccine revenue. This includes BioNTech (BNTX), Moderna (MRNA), and Novavax (NASDAQ:NVAX).However, there is some comfort for them in that they still have orders to fill from the U.S. and many other countries. That should keep them busy through 2022. But beyond that is a question mark at this point.There is also a need to provide initial vaccination and first booster shots in many poorer countries that could sustain the biotechs longer. But at some point -- and perhaps sooner than expected -- they will need to find other revenue streams in their pipelines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":1304,"commentSize":121,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}